Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trialWookjin Yang, Seung‐Hoon Lee, Seong‐Ho Koh et al.|Contemporary Clinical Trials|2025Cited by 0